chr19-16896503-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_015692.5(CPAMD8):c.5228G>T(p.Arg1743Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000743 in 1,426,424 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015692.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CPAMD8 | NM_015692.5 | c.5228G>T | p.Arg1743Leu | missense_variant | 40/42 | ENST00000443236.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CPAMD8 | ENST00000443236.7 | c.5228G>T | p.Arg1743Leu | missense_variant | 40/42 | 1 | NM_015692.5 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152060Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000271 AC: 11AN: 40540Hom.: 0 AF XY: 0.000232 AC XY: 5AN XY: 21596
GnomAD4 exome AF: 0.0000753 AC: 96AN: 1274256Hom.: 1 Cov.: 32 AF XY: 0.000108 AC XY: 67AN XY: 621686
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152168Hom.: 1 Cov.: 31 AF XY: 0.0000672 AC XY: 5AN XY: 74410
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2024 | The c.5369G>T (p.R1790L) alteration is located in exon 40 (coding exon 40) of the CPAMD8 gene. This alteration results from a G to T substitution at nucleotide position 5369, causing the arginine (R) at amino acid position 1790 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at